We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Workstation Automates Microarray Processing

By Biotechdaily staff writers
Posted on 08 Aug 2002
A new workstation completely automates the processing of microscope slide-based protein microarrays.

The Protein Array Workstation employs a microfluidics system, full software control interface and bar-code tracking capability for future integration into other protein microarray technologies. The workstation can automate almost any protein microarray assay, says the developer, PerkinElmer Life Sciences (Boston, MA, USA). The system was developed to use very low sample volumes, which is particularly important where sample amounts are small.

An additional capability of the system is the Tyramide Signal Amplification (TSA) chemistries. TSA employs an enzyme-mediated detection method that uses the catalytic activity of horseradish peroxidase to generate high-density labeling of a target protein. The workstation has been validated for a number of key assays, including protein expression analysis, selection of content and high specificity binders, antibody profiling, and protein-protein interaction sites.

Recently, PerkinElmer announced the availability of its Micromax Human cDNA Microarray System II-TSA, a complete system incorporating gene content from Incyte Genomics (Palo Alto, CA, USA). The microarray features sequence-verified human drug target genes mined from Incyte's LifeSeq Gold database and PerkinElmer's TSA amplification technology. "With Incyte Genomics, PerkinElmer Life Sciences can now offer its customers a microarray solution from the largest collection of gene content currently available,” said Paul Gillyon, vice president and general manager, Biomics, PerkinElmer.




Related Links:
PerkinElmer

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Rapid Molecular Testing Device
FlashDetect Flash10

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
08 Aug 2002  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
08 Aug 2002  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
08 Aug 2002  |   BioResearch